Squamous Cell Carcinoma — Trials

Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,930 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 976
Recruiting: 519
Ph III recruiting: 60
Growth YoY: +44.4%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (402)

clinicaltrialsPublishedShowing 501–550 of 601 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06710665	Tumor Regression Grade As Predictor of Adjuvant Therapy	recruiting	—	400	Fujian Medical University Union HospitalOTHER	1	Nov 29, 2024	clinicaltrials
NCT04787042	Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067	recruiting	Phase 1 / Phase 2	316	Simcha IL-18, Inc.INDUSTRY	1	Nov 15, 2024	clinicaltrials